KRYS
Krystal Biotech Inc
NASDAQ: KRYS · HEALTHCARE · BIOTECHNOLOGY
$259.95
-3.46% today
Updated 2026-04-29
Market cap
$7.65B
P/E ratio
38.06
P/S ratio
19.66x
EPS (TTM)
$6.83
Dividend yield
—
52W range
$123 – $298
Volume
0.3M
Krystal Biotech Inc (KRYS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+43.4%
Last 4 quarters
Revenue YoY growth
+17.5%
Most recent quarter
EPS YoY growth
+11.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.4%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-12.5%
2025-08-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-17 | $1.70 | +7.6% | $276.45 | $283.29 | +2.5% |
| 2025-11-03 | $2.66 | +144.0% | $197.51 | $203.26 | +2.9% |
| 2025-08-04 | $1.29 | +5.7% | $156.98 | $137.35 | -12.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $1.58 | $1.70 | +7.6% | $107.11M | +17.5% |
| 2025-09-30 | $1.09 | $2.66 | +144.0% | $97.80M | +16.6% |
| 2025-06-30 | $1.22 | $1.29 | +5.7% | $96.04M | +36.6% |
| 2025-03-31 | $1.03 | $1.20 | +16.1% | $88.18M | +94.9% |
| 2024-12-31 | $1.85 | $1.53 | -17.4% | $91.14M | +116.3% |
| 2024-09-30 | $0.90 | $0.91 | +1.1% | $83.84M | +879.9% |
| 2024-06-30 | $0.58 | $0.53 | -8.6% | $70.28M | — |
| 2024-03-31 | $0.15 | $0.03 | -80.0% | $45.25M | — |
| 2023-12-31 | $-0.38 | $0.30 | +178.9% | $42.14M | — |
| 2023-09-30 | $-0.29 | $-0.69 | -137.9% | $8.56M | — |
| 2023-06-30 | $-0.74 | $-1.25 | -68.9% | — | — |
Frequently asked questions
Has Krystal Biotech Inc beaten earnings estimates?
Krystal Biotech Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +43.4% over the last 4 quarters.
How does KRYS stock react to earnings?
KRYS stock has moved an average of -2.4% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Krystal Biotech Inc's revenue growth rate?
Krystal Biotech Inc reported year-over-year revenue growth of +17.5% in its most recent quarter, with EPS growing +11.1% year-over-year.